modified Herpes simplex virus 1 vaccine vector (Havard)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namemodified Herpes simplex virus 1 vaccine vector (Havard)

Drug Alias NameN/A

ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Recombinant vector vaccineVaccines > Application > Prophylactic vaccine +[4]

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsHerpes Simplex Virus Type 1 Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesHarvard Medical School

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesHarvard Medical School

Active IndicationsN/A

Inactive IndicationsHerpes Simplex Virus Type 1 Infections

Other Information

ATC CodeN/A